Research & analysis only — not investment advice

Quince Therapeutics, Inc. (QNCX)

Healthcare · Biological Products, (No Diagnostic Substances)

Quince Therapeutics, Inc. operates in Healthcare, within the Biological Products, (No Diagnostic Substances) industry.

Quince Therapeutics, Inc. key market context on AlphaOS includes Sector: Healthcare; Industry: Biological Products, (No Diagnostic Substances); Market capitalization: $15.12M; Recent price: $0.93. Figures update as market data and SEC filings are ingested.

Peers and competitive context often cited for Quince Therapeutics, Inc. include GILD, BIIB, MRNA, TECH, TWST, CPMV. Explore industry and sector pages on AlphaOS for thematic exposure and supply-chain links.

Use this QNCX research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$15.12M

Peers & related names

  • GILD
  • BIIB
  • MRNA
  • TECH
  • TWST
  • CPMV
  • LLY
  • JNJ

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

QNCX

Quince Therapeutics, Inc.

Healthcare · Biological Products, (No Diagnostic Substances)

$0.93Jun 18, 2026

AI confidence 70% · prior close shown (market closed)

Filing insights

Loading SEC filing intelligence…

SEC filings

10-K, 10-Q, 8-K, 20-F, 6-K from EDGAR — HTML & PDF stored in GCS

No filings yet

Ingest recent SEC filings for QNCX to enable RAG search and AI risk analysis.